- Home
- VIST vs ELAN Comparison
VIST vs ELAN Comparison
Compare VIST & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIST
- ELAN
- Stock Information
- Founded
- VIST 2017
- ELAN 1954
- Country
- VIST Mexico
- ELAN United States
- Employees
- VIST N/A
- ELAN N/A
- Industry
- VIST Oil & Gas Production
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- VIST Energy
- ELAN Health Care
- Exchange
- VIST Nasdaq
- ELAN Nasdaq
- Market Cap
- VIST 4.7B
- ELAN 5.4B
- IPO Year
- VIST 2019
- ELAN 2018
- Fundamental
- Price
- VIST $47.48
- ELAN $10.42
- Analyst Decision
- VIST Strong Buy
- ELAN Buy
- Analyst Count
- VIST 5
- ELAN 6
- Target Price
- VIST $64.60
- ELAN $15.00
- AVG Volume (30 Days)
- VIST 898.2K
- ELAN 3.8M
- Earning Date
- VIST 04-23-2025
- ELAN 05-07-2025
- Dividend Yield
- VIST N/A
- ELAN N/A
- EPS Growth
- VIST 15.82
- ELAN N/A
- EPS
- VIST 4.63
- ELAN 0.68
- Revenue
- VIST $1,647,768,000.00
- ELAN $4,439,000,000.00
- Revenue This Year
- VIST $29.02
- ELAN $3.20
- Revenue Next Year
- VIST $19.76
- ELAN $4.26
- P/E Ratio
- VIST $9.70
- ELAN $15.12
- Revenue Growth
- VIST 40.98
- ELAN 0.50
- 52 Week Low
- VIST $36.01
- ELAN $10.03
- 52 Week High
- VIST $61.67
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- VIST 49.43
- ELAN 42.62
- Support Level
- VIST $45.67
- ELAN $10.45
- Resistance Level
- VIST $49.61
- ELAN $10.85
- Average True Range (ATR)
- VIST 1.85
- ELAN 0.36
- MACD
- VIST 0.47
- ELAN 0.03
- Stochastic Oscillator
- VIST 79.71
- ELAN 40.10
About VIST Vista Energy S.A.B. de C.V. each representing one series A share with no par value
Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, It operates in Argentina and Mexico. it generates the majority of its revenue from Argentina.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.